首页 > 最新文献

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan最新文献

英文 中文
Weifuchun ( ) exerts therapeutic effects on gastric fundic gland polyps by promoting ferroptosis. 胃复春对胃底腺息肉有促进铁下垂的治疗作用。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.20250515.001
L I Yue, Deng Jinyan, P I Shanshan, Zhang Yingjuan, Zhao Dan, Guo Yi, Y E Yong'an, Zao Xiaobin, D U Hongbo

Objective: To investigate the therapeutic effects of Chinese medicine Weifuchun (WFC, ) on gastric fundic gland polyps (FGPs).

Methods: FGPs organoids were constructed with patients-derived samples. The morphology and size of FGPs organoids were detected using bright-field imaging. Effective components and corresponding potential targets of WFC were screened using multiple open-source databases and research on Traditional Chinese Medicine or compound formulas. Core genes were identified through protein-protein interaction networks. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses of the core genes were conducted. The interactions between main components and core targets were analyzed through the FerrDb database. The expressions of core targets were detected by quantitative real-time polymerase chain reaction (qRT-PCR).

Results: After WFC treatment, the number and size of FGPs organoids were significantly reduced. Twenty nine active drug components and 162 candidate targets of WFC for treating FGPs were identified, including 37 targets related to ferroptosis. Quercetin, Glaucocalyxin B, Melissoidesin U, Melissoidesin O, Hesperetin, Glaucocalyxin A, Angustifolin, Melissoidesin M, Di-n-octyl phthalate, and beta-sitosterol were identified as the main active compounds. SRC proto-oncogene, non-receptor tyrosine kinase, signal transducer and activator of transcription 3, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta, phosphoinositide-3-kinase regulatory subunit 1, and AKT serine/threonine kinase 1 were identified as the primary targets. KEGG pathways related to carcinogenesis, cell proliferation and metabolism, and oxidative stress. WFC promoted FGPs organoids' death and could be reversed by ferroptosis inhibitor of Erastin. The qRT-PCR results showed that WFC treatment could regulate the mRNA expression levels of solute carrier family 7 member 11, acyl-CoA synthetase long chain family member 4, and arachidonate 15-lipoxygenase, type B.

Conclusion: WFC may exert its therapeutic effects by inducing ferroptosis in FGPs cells.

目的:观察中药胃复春对胃底腺息肉的治疗作用。方法:用患者源性标本构建FGPs类器官。采用明场成像技术检测FGPs类器官的形态和大小。通过多个开源数据库和中药或复方研究,筛选WFC的有效成分和相应的潜在靶点。通过蛋白-蛋白相互作用网络鉴定核心基因。对核心基因进行京都基因与基因组百科全书(KEGG)和基因本体(GO)富集分析。通过FerrDb数据库分析主要部件与核心目标之间的相互作用。采用实时荧光定量聚合酶链反应(qRT-PCR)检测核心靶点的表达。结果:经WFC处理后,fgp类器官的数量和大小均明显减少。共鉴定出WFC治疗fgp的活性成分29个,候选靶点162个,其中与铁下垂相关的靶点37个。槲皮素、青花花素B、青花花素U、青花花素O、橙皮素、青花花素A、Angustifolin、青花花素M、邻苯二甲酸二辛酯和β -谷甾醇为主要活性成分。SRC原癌基因、非受体酪氨酸激酶、信号转导和转录激活因子3、磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α、磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基β、磷脂酰肌醇-3-激酶调控亚基1和AKT丝氨酸/苏氨酸激酶1被确定为主要靶点。KEGG通路与癌变、细胞增殖和代谢以及氧化应激有关。WFC可促进fgp类器官的死亡,并可通过Erastin抑制剂逆转。qRT-PCR结果显示,WFC处理可调节溶质载体家族7成员11、酰基辅酶a合成酶长链家族成员4、花生四烯酸15-脂氧合酶b型mRNA表达水平。结论:WFC可能通过诱导fgp细胞铁下垂发挥其治疗作用。
{"title":"Weifuchun ( ) exerts therapeutic effects on gastric fundic gland polyps by promoting ferroptosis.","authors":"L I Yue, Deng Jinyan, P I Shanshan, Zhang Yingjuan, Zhao Dan, Guo Yi, Y E Yong'an, Zao Xiaobin, D U Hongbo","doi":"10.19852/j.cnki.jtcm.20250515.001","DOIUrl":"10.19852/j.cnki.jtcm.20250515.001","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the therapeutic effects of Chinese medicine Weifuchun (WFC, ) on gastric fundic gland polyps (FGPs).</p><p><strong>Methods: </strong>FGPs organoids were constructed with patients-derived samples. The morphology and size of FGPs organoids were detected using bright-field imaging. Effective components and corresponding potential targets of WFC were screened using multiple open-source databases and research on Traditional Chinese Medicine or compound formulas. Core genes were identified through protein-protein interaction networks. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses of the core genes were conducted. The interactions between main components and core targets were analyzed through the FerrDb database. The expressions of core targets were detected by quantitative real-time polymerase chain reaction (qRT-PCR).</p><p><strong>Results: </strong>After WFC treatment, the number and size of FGPs organoids were significantly reduced. Twenty nine active drug components and 162 candidate targets of WFC for treating FGPs were identified, including 37 targets related to ferroptosis. Quercetin, Glaucocalyxin B, Melissoidesin U, Melissoidesin O, Hesperetin, Glaucocalyxin A, Angustifolin, Melissoidesin M, Di-n-octyl phthalate, and beta-sitosterol were identified as the main active compounds. SRC proto-oncogene, non-receptor tyrosine kinase, signal transducer and activator of transcription 3, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta, phosphoinositide-3-kinase regulatory subunit 1, and AKT serine/threonine kinase 1 were identified as the primary targets. KEGG pathways related to carcinogenesis, cell proliferation and metabolism, and oxidative stress. WFC promoted FGPs organoids' death and could be reversed by ferroptosis inhibitor of Erastin. The qRT-PCR results showed that WFC treatment could regulate the mRNA expression levels of solute carrier family 7 member 11, acyl-CoA synthetase long chain family member 4, and arachidonate 15-lipoxygenase, type B.</p><p><strong>Conclusion: </strong>WFC may exert its therapeutic effects by inducing ferroptosis in FGPs cells.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"618-627"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture with different frequencies for tobacco dependence: a randomized controlled trial. 不同频率针灸治疗烟草依赖:一项随机对照试验。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.022
Chen Shumin, Liu Zhenyu, J I Jia, Chang Jin, L I Zhihua, Wang Yingying, Yang Jinsheng

Objective: To observe the effect of different acupuncture frequencies on the abstinence rate which could be used as a reference for optimizing acupuncture cessation programs.

Methods: From July 2018 to June 2022, a total of 220 smokers were recruited based on inclusion criteria and randomly divided into the high-frequency acupuncture group (HF group, n = 110): 5 times a week from the 1st to the 4th week, from weeks 5 to 8, three times a week and the low-frequency acupuncture group (LF group, n = 110): 3 times a week from the 1st to the 4th week, from weeks 5 to 8, twice a week, then treated for 8 weeks and follow-up at 1 month in Beijing.

Results: In total, 162 subjects completed the whole study with a drop-out rate of 20.45%. The expiratory CO point abstinence rate was HF group 53/110 (48.18%) vs LF group 41/110 (37.27%) in Week 8 (P = 0.102) and HF group 46/110 (41.82%) vs LF group 45/110 (40.91%) in Week 12 (P = 0.891) and the HF acupuncture and LF acupuncture were nearly equal in the 8-week abstinence rate. In addition, both HF and LF acupuncture significantly reduced Fagerstrőm test for nicotine dependence scale (FTND) scores (P < 0.05), Minnesota nicotine withdrawal scale (MNWS) scores (P < 0.05), and Brief Questionnaire of Smoking Urges scale (QSU-Brief) scores (P < 0.05), but HF acupuncture showed some superiority over LF acupuncture in relieving patients' smoking cravings (P < 0.05).

Conclusions: The study initially showed that both high-frequency acupuncture and low-frequency acupuncture treatment were safe and effective on smoking cessation for 8 weeks, but high-frequency acupuncture was advantageous in reducing smoking cravings. More accurate acupuncture frequency needs to be validated through larger clinical studies to optimize acupuncture smoking cessation programs.

目的:观察不同针灸频率对戒断率的影响,为优化针灸戒烟方案提供参考。方法:从2018年7月到2022年6月,总共有220吸烟者招募根据入选标准和随机分为高频针灸组(高频组,n = 110):每周5次从1日到4日一周,从星期5到8,每周3次和低频针灸组(低频组,n = 110):每周3次从1日到4日一周,从星期5到8,每周两次,然后治疗8周,随访1个月在北京。结果:162名受试者完成了整个研究,退出率为20.45%。第8周呼气CO点戒断率HF组53/110 (48.18%)vs LF组41/110 (37.27%)(P = 0.102),第12周HF组46/110 (41.82%)vs LF组45/110 (40.91%)(P = 0.891),且HF针与LF针在8周戒断率基本相等。此外,高频针和低频针均显著降低Fagerstrőm尼古丁依赖量表(FTND)得分、明尼苏达尼古丁戒断量表(MNWS)得分和吸烟冲动简易问卷(QSU-Brief)得分(P 0.05),但高频针在缓解患者吸烟渴望方面优于低频针(P < 0.05)。结论:本研究初步表明,高频针刺和低频针刺治疗对戒烟8周均安全有效,但高频针刺在减少吸烟欲望方面具有优势。更准确的针灸频率需要通过更大的临床研究来验证,以优化针灸戒烟计划。
{"title":"Acupuncture with different frequencies for tobacco dependence: a randomized controlled trial.","authors":"Chen Shumin, Liu Zhenyu, J I Jia, Chang Jin, L I Zhihua, Wang Yingying, Yang Jinsheng","doi":"10.19852/j.cnki.jtcm.2025.03.022","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.022","url":null,"abstract":"<p><strong>Objective: </strong>To observe the effect of different acupuncture frequencies on the abstinence rate which could be used as a reference for optimizing acupuncture cessation programs.</p><p><strong>Methods: </strong>From July 2018 to June 2022, a total of 220 smokers were recruited based on inclusion criteria and randomly divided into the high-frequency acupuncture group (HF group, <i>n =</i> 110): 5 times a week from the 1st to the 4th week, from weeks 5 to 8, three times a week and the low-frequency acupuncture group (LF group, <i>n</i> = 110): 3 times a week from the 1st to the 4th week, from weeks 5 to 8, twice a week, then treated for 8 weeks and follow-up at 1 month in Beijing.</p><p><strong>Results: </strong>In total, 162 subjects completed the whole study with a drop-out rate of 20.45%. The expiratory CO point abstinence rate was HF group 53/110 (48.18%) <i>vs</i> LF group 41/110 (37.27%) in Week 8 (<i>P =</i> 0.102) and HF group 46/110 (41.82%) <i>vs</i> LF group 45/110 (40.91%) in Week 12 (<i>P =</i> 0.891) and the HF acupuncture and LF acupuncture were nearly equal in the 8-week abstinence rate. In addition, both HF and LF acupuncture significantly reduced Fagerstrőm test for nicotine dependence scale (FTND) scores (<i>P <</i> 0.05), Minnesota nicotine withdrawal scale (MNWS) scores (<i>P <</i> 0.05), and Brief Questionnaire of Smoking Urges scale (QSU-Brief) scores (<i>P <</i> 0.05), but HF acupuncture showed some superiority over LF acupuncture in relieving patients' smoking cravings (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>The study initially showed that both high-frequency acupuncture and low-frequency acupuncture treatment were safe and effective on smoking cessation for 8 weeks, but high-frequency acupuncture was advantageous in reducing smoking cravings. More accurate acupuncture frequency needs to be validated through larger clinical studies to optimize acupuncture smoking cessation programs.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"651-659"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bushen Tongluo recipe improves oxidative stress homeostasis, inhibits transforming growth factor/Notch signaling pathway, and regulates the lncRNA maternally expressed gene 3/miR-145 axis to delay diabetic kidney disease. 补肾通络方改善氧化应激稳态,抑制转化生长因子/Notch信号通路,调节lncRNA母系表达基因3/miR-145轴延缓糖尿病肾病。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.011
X U Bojun, Tao Tian, Zhao Liangbin, Zheng Hui, Zhan Huakui, Guo Julan

Objectives: To investigate the effect of Bushen Tongluo recipe (BSTLR, ) on rats with diabetic kidney disease (DKD) and to explore the underlying mechanism of action.

Methods: The rat model of DKD was established, and rats were treated with different doses of BSTLR. Body weight and the levels of urinary protein, α1-microglobulin, glucose, blood urea nitrogen, creatinine, Cystatin C, superoxide dismutase, malondialdehyde, and catalase were analyzed biochemically or by enzyme-linked immunosorbent assay. The pathological damage to renal tissues was assessed by hematoxylin-eosin staining. Immunohistochemical staining was carried out to detect the expression levels of fibronectin, E-cadherin, α-smooth muscle actin, laminin, vimentin, collagen type Ⅳ in kidney tissues. Western blot analysis was conducted to analyze the expression levels of Nephrin, Desmin, Podocin, transforming growth factor-β1, mothers against decapentaplegic homolog 3 (Smad3), Notch1, jagged, hairy and enhancer of split 1 (Hes1) in kidney tissues, and the expression levels of maternally expressed gene 3 (MEG3) and miR-145 were measured by quantitative reverse transcription-polymerase chain reaction. Moreover, dual-luciferase reporter assay was employed to verify the binding of miR-145 to MEG3.

Results: BSTLR increased the body weight of DKD rats, effectively ameliorated the renal function and pathological injury in DKD, regulated the balance of renal oxidative stress, inhibited the TGF/Notch signaling pathway, and affected the variations in the lncRNA MEG3/miR-145 axis.

Conclusion: BSTLR improved oxidative stress homeostasis, inhibited the TGF/Notch signaling pathway, and regulated the lncRNA MEG3/miR-145 axis, effectively delaying the progression of DKD.

目的:观察补肾通络方对糖尿病肾病(DKD)大鼠的影响,并探讨其作用机制。方法:建立大鼠DKD模型,给予不同剂量的BSTLR治疗。采用生化或酶联免疫吸附法分析体重、尿蛋白、α - 1微球蛋白、葡萄糖、血尿素氮、肌酐、胱抑素C、超氧化物歧化酶、丙二醛和过氧化氢酶水平。苏木精-伊红染色评价肾组织病理损伤。采用免疫组化染色检测肾组织中纤维连接蛋白、e -钙粘蛋白、α-平滑肌肌动蛋白、层粘连蛋白、波形蛋白、胶原型Ⅳ的表达水平。采用Western blot方法分析肾组织中Nephrin、Desmin、Podocin、转化生长因子-β1、抗十肢不全母同源物3 (Smad3)、Notch1、jagged、hairy和split 1增强子(Hes1)的表达水平,采用定量逆转录-聚合酶链反应检测母表达基因3 (MEG3)和miR-145的表达水平。此外,采用双荧光素酶报告试验验证miR-145与MEG3的结合。结果:BSTLR可增加DKD大鼠体重,有效改善DKD的肾功能和病理损伤,调节肾脏氧化应激平衡,抑制TGF/Notch信号通路,影响lncRNA MEG3/miR-145轴的变异。结论:BSTLR改善氧化应激稳态,抑制TGF/Notch信号通路,调节lncRNA MEG3/miR-145轴,有效延缓DKD的进展。
{"title":"Bushen Tongluo recipe improves oxidative stress homeostasis, inhibits transforming growth factor/Notch signaling pathway, and regulates the lncRNA maternally expressed gene 3/miR-145 axis to delay diabetic kidney disease.","authors":"X U Bojun, Tao Tian, Zhao Liangbin, Zheng Hui, Zhan Huakui, Guo Julan","doi":"10.19852/j.cnki.jtcm.2025.03.011","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.011","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the effect of Bushen Tongluo recipe (BSTLR, ) on rats with diabetic kidney disease (DKD) and to explore the underlying mechanism of action.</p><p><strong>Methods: </strong>The rat model of DKD was established, and rats were treated with different doses of BSTLR. Body weight and the levels of urinary protein, α1-microglobulin, glucose, blood urea nitrogen, creatinine, Cystatin C, superoxide dismutase, malondialdehyde, and catalase were analyzed biochemically or by enzyme-linked immunosorbent assay. The pathological damage to renal tissues was assessed by hematoxylin-eosin staining. Immunohistochemical staining was carried out to detect the expression levels of fibronectin, E-cadherin, α-smooth muscle actin, laminin, vimentin, collagen type Ⅳ in kidney tissues. Western blot analysis was conducted to analyze the expression levels of Nephrin, Desmin, Podocin, transforming growth factor-β1, mothers against decapentaplegic homolog 3 (Smad3), Notch1, jagged, hairy and enhancer of split 1 (Hes1) in kidney tissues, and the expression levels of maternally expressed gene 3 (MEG3) and miR-145 were measured by quantitative reverse transcription-polymerase chain reaction. Moreover, dual-luciferase reporter assay was employed to verify the binding of miR-145 to MEG3.</p><p><strong>Results: </strong>BSTLR increased the body weight of DKD rats, effectively ameliorated the renal function and pathological injury in DKD, regulated the balance of renal oxidative stress, inhibited the TGF/Notch signaling pathway, and affected the variations in the lncRNA MEG3/miR-145 axis.</p><p><strong>Conclusion: </strong>BSTLR improved oxidative stress homeostasis, inhibited the TGF/Notch signaling pathway, and regulated the lncRNA MEG3/miR-145 axis, effectively delaying the progression of DKD.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"561-570"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Neibu Huangqi Youhua formula on postoperative wound healing, inflammatory factors and pain mediators of anal fistula. 内补黄芪油花方对肛瘘术后创面愈合、炎症因子及疼痛介质的影响。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.015
Xiong Yanyan, Tang Renjin, L I Xuelin, Liu Hong

Objective: To explore the clinical efficacy of the Chinese medicine, Neibu Huangqi Youhua formula combined with Kangfuxin solution for the nursing of patients after anal fistula surgery.

Methods: A total of 160 cases with anal fistula who underwent surgical treatment were recruited, and divided into control group (treated with external application of Kangfuxin liquid gauze) and experimental group (receiving the Neibu Huangqi Youhua formula combined with Kangfuxin liquid gauze) based on a random numbering table. The wound recovery, postoperative pain and inflammation were evaluated and compared between the two groups.

Results: At 3, 7, and 14 d after the operation, the wound healing rate of the experimental group was significantly higher than that of the control group at any time point. The visual analogue scale scores of the two groups gradually decreased in a time-dependent manner after surgery, while the experimental group showed a more significant downward trend in comparison with the control group. At 14 d after the operation, the experimental group had high levels of epidermal growth factor, fibroblast growth factor-1, secretory IgA, tissue inhibitor of matrix metalloproteinase-1, 5-hydroxytryptamine, prostaglandin E-2, substances P and neuropeptide Y compared with control group, but low levels of C-reactive protein, procalcitonin, and serum amyloid A protein.

Conclusions: The Neibu Huangqi Youhua formula can reduce the levels of inflammatory factors and pain mediators in patients after anal fistula surgery, thereby accelerating the process of wound healing and alleviating the pain of patients.

目的:探讨中药内补黄芪油花方联合抗复心液对肛瘘术后患者护理的临床疗效。方法:选取手术治疗的肛瘘患者160例,按随机编号表法分为对照组(外敷康复新液纱布治疗)和实验组(内补黄芪油花方联合康复新液纱布治疗)。比较两组患者伤口恢复情况、术后疼痛和炎症情况。结果:术后3、7、14 d,实验组各时间点创面愈合率均显著高于对照组。两组术后视觉模拟量表评分呈时间依赖性逐渐下降,实验组较对照组下降趋势更为明显。术后14 d,实验组表皮生长因子、成纤维细胞生长因子-1、分泌IgA、基质金属蛋白酶组织抑制剂- 1,5 -羟色胺、前列腺素E-2、P物质、神经肽Y水平均高于对照组,c反应蛋白、降钙素原、血清淀粉样蛋白A水平低于对照组。结论:内补黄芪油花方可降低肛瘘术后患者炎症因子及疼痛介质水平,从而加快创面愈合进程,减轻患者疼痛。
{"title":"Effect of Neibu Huangqi Youhua formula on postoperative wound healing, inflammatory factors and pain mediators of anal fistula.","authors":"Xiong Yanyan, Tang Renjin, L I Xuelin, Liu Hong","doi":"10.19852/j.cnki.jtcm.2025.03.015","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.015","url":null,"abstract":"<p><strong>Objective: </strong>To explore the clinical efficacy of the Chinese medicine, Neibu Huangqi Youhua formula combined with Kangfuxin solution for the nursing of patients after anal fistula surgery.</p><p><strong>Methods: </strong>A total of 160 cases with anal fistula who underwent surgical treatment were recruited, and divided into control group (treated with external application of Kangfuxin liquid gauze) and experimental group (receiving the Neibu Huangqi Youhua formula combined with Kangfuxin liquid gauze) based on a random numbering table. The wound recovery, postoperative pain and inflammation were evaluated and compared between the two groups.</p><p><strong>Results: </strong>At 3, 7, and 14 d after the operation, the wound healing rate of the experimental group was significantly higher than that of the control group at any time point. The visual analogue scale scores of the two groups gradually decreased in a time-dependent manner after surgery, while the experimental group showed a more significant downward trend in comparison with the control group. At 14 d after the operation, the experimental group had high levels of epidermal growth factor, fibroblast growth factor-1, secretory IgA, tissue inhibitor of matrix metalloproteinase-1, 5-hydroxytryptamine, prostaglandin E-2, substances P and neuropeptide Y compared with control group, but low levels of C-reactive protein, procalcitonin, and serum amyloid A protein.</p><p><strong>Conclusions: </strong>The Neibu Huangqi Youhua formula can reduce the levels of inflammatory factors and pain mediators in patients after anal fistula surgery, thereby accelerating the process of wound healing and alleviating the pain of patients.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"628-632"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical observation on the effect of warming meridian medicinal wine, polarized light external application combined with acupuncture and moxibustion on pain after vertebroplasty. 温经药酒、偏振光外敷配合针灸治疗椎体成形术后疼痛的临床观察。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.018
Wen Zhigang, L U Shuai, Cheng Xiumei

Objective: To evaluate the effects of external application of warm meridian medicated wine and polarized light therapy combined with acupuncture on pain management following vertebroplasty.

Methods: A total of 120 patients with osteoporotic vertebral compression fractures treated by vertebroplasty at our hospital were divided into four groups. The control group received non-steroidal anti-inflammatory drugs, the Treatment Group Ⅰ received acupuncture alone, Treatment Group Ⅱ was treated with medicated wine for warming meridians alongside polarized light physiotherapy, and Treatment Group Ⅲ received a combination of medicated wine for warming meridians, polarized light therapy, and acupuncture. The clinical efficacy, pain thresholds at various time points, temperature pain threshold, electric pain threshold, quality of life, sleep quality index, lumbar dysfunction index, visual analog scale (VAS) scores, and incidence of adverse reactions were compared and analyzed across the four groups.

Results: The total clinical effective rate in Treatment Group Ⅲ was significantly higher than that in the control group, Treatment Group Ⅰ, and Treatment Group Ⅱ (P < 0.05). At 24 and 72 h post-treatment, the VAS scores, temperature pain thresholds, and electric pain thresholds in Treatment Group Ⅲ were significantly lower than those in the control group, Treatment Group Ⅰ, and Treatment Group Ⅱ (P < 0.05). Additionally, quality-of-life scores in Treatment Group Ⅲ were markedly higher compared to the control group, Treatment Group Ⅰ, and Treatment Group Ⅱ, while the Pittsburgh Sleep Quality Index scores, Oswestry Disability Index scores, and incidence of adverse reactions in Treatment Group Ⅲ were significantly lower than in the other groups (P < 0.05).

Conclusion: The external application of warm meridian medicated wine and polarized light therapy combined with acupuncture significantly reduces postoperative pain following vertebroplasty, enhances lumbar function, and improves both sleep quality and overall quality of life for patients. This approach is recommended for clinical application.

目的:探讨温经药酒外敷和偏振光疗法结合针灸治疗椎体成形术后疼痛的疗效。方法:将我院行椎体成形术治疗的骨质疏松性椎体压缩性骨折患者120例分为4组。对照组采用非甾体类抗炎药治疗,治疗组Ⅰ单独采用针灸治疗,治疗组Ⅱ采用温经药酒加偏振光理疗,治疗组Ⅲ采用温经药酒加偏振光疗法加针灸治疗。比较分析四组患者的临床疗效、各时间点疼痛阈值、温度疼痛阈值、电疼痛阈值、生活质量、睡眠质量指数、腰椎功能障碍指数、视觉模拟评分(VAS)评分及不良反应发生率。结果:治疗组临床总有效率Ⅲ显著高于对照组、治疗组Ⅰ和治疗组Ⅱ(P < 0.05)。治疗后24、72 h,治疗组Ⅲ的VAS评分、温度痛阈值、电痛阈值均显著低于对照组、治疗组Ⅰ、治疗组Ⅱ(P < 0.05)。治疗组Ⅲ的生活质量评分显著高于对照组、治疗组Ⅰ和治疗组Ⅱ,治疗组Ⅲ的匹兹堡睡眠质量指数评分、Oswestry残疾指数评分和不良反应发生率显著低于其他组(P < 0.05)。结论:温经药酒外敷、偏振光疗法配合针灸治疗可明显减轻椎体成形术术后疼痛,增强腰椎功能,改善患者睡眠质量和整体生活质量。推荐临床应用该方法。
{"title":"Clinical observation on the effect of warming meridian medicinal wine, polarized light external application combined with acupuncture and moxibustion on pain after vertebroplasty.","authors":"Wen Zhigang, L U Shuai, Cheng Xiumei","doi":"10.19852/j.cnki.jtcm.2025.03.018","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.018","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effects of external application of warm meridian medicated wine and polarized light therapy combined with acupuncture on pain management following vertebroplasty.</p><p><strong>Methods: </strong>A total of 120 patients with osteoporotic vertebral compression fractures treated by vertebroplasty at our hospital were divided into four groups. The control group received non-steroidal anti-inflammatory drugs, the Treatment Group Ⅰ received acupuncture alone, Treatment Group Ⅱ was treated with medicated wine for warming meridians alongside polarized light physiotherapy, and Treatment Group Ⅲ received a combination of medicated wine for warming meridians, polarized light therapy, and acupuncture. The clinical efficacy, pain thresholds at various time points, temperature pain threshold, electric pain threshold, quality of life, sleep quality index, lumbar dysfunction index, visual analog scale (VAS) scores, and incidence of adverse reactions were compared and analyzed across the four groups.</p><p><strong>Results: </strong>The total clinical effective rate in Treatment Group Ⅲ was significantly higher than that in the control group, Treatment Group Ⅰ, and Treatment Group Ⅱ (<i>P <</i> 0.05). At 24 and 72 h post-treatment, the VAS scores, temperature pain thresholds, and electric pain thresholds in Treatment Group Ⅲ were significantly lower than those in the control group, Treatment Group Ⅰ, and Treatment Group Ⅱ (<i>P <</i> 0.05). Additionally, quality-of-life scores in Treatment Group Ⅲ were markedly higher compared to the control group, Treatment Group Ⅰ, and Treatment Group Ⅱ, while the Pittsburgh Sleep Quality Index scores, Oswestry Disability Index scores, and incidence of adverse reactions in Treatment Group Ⅲ were significantly lower than in the other groups (<i>P <</i> 0.05).</p><p><strong>Conclusion: </strong>The external application of warm meridian medicated wine and polarized light therapy combined with acupuncture significantly reduces postoperative pain following vertebroplasty, enhances lumbar function, and improves both sleep quality and overall quality of life for patients. This approach is recommended for clinical application.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"660-666"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the mechanism of Shenhua tablet alleviating renal injury by regulating macrophage glycolysis hypoxia-inducible factor-1α/ pyruvate kinase M2 signaling pathway in diabetic kidney disease mice. 探讨参花片通过调节糖尿病肾病小鼠巨噬细胞糖酵解缺氧诱导因子-1α/丙酮酸激酶M2信号通路减轻肾损伤的机制。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.009
Chen Yuanchun, Jing Jiaxing, L I Qingmin, Zhou Xiaohong, Jin Xiaofei, Gao Weijuan, Chen Xiangmei, Y U Wentao

Objective: To investigate the impact of Shenhua tablet (, SHT) on renal macrophage polarization and renal injury in mice with diabetic kidney disease (DKD)and to explore the potential mechanism involving the hypoxia-inducible factor-1α (HIF-1α) and pyruvate kinase M2 (PKM2) signaling pathway, along with the glycolysis metabolism pathway.

Methods: The animals were divided into the following groups: Model, Control, dapagliflozin, SHT low-dose, SHT medium-dose, and SHT high-dose. We assessed 24-hour urine protein (24 h-UTP) levels, urinary albumin-to-creatinine ratio, and regularly monitored fasting blood glucose during the treatment period. After treatment, we examined renal tissue structure, renal function (urea nitrogen, uric acid, creatinine, cystatin C, β2-microglobulin), and glycolysis in renal macrophages. Additionally, we observed macrophage polarization in renal tissue and measured inflammatory factors (tumor necrosis factor-α, interleukin-1β, interleukin-6, interleukin-10, monocyte chemoattractant protein-1) to assess the immunoinflammatory status of the renal tissue. Finally, we investigated the expression of the HIF-1α/ PKM2 signaling pathway in macrophages to explore its role in the glycolysis process.

Results: SHT shows a beneficial effect in treating DKD by reducing 24 h-UTP, regulating blood glucose levels, improving renal tissue structure, protecting renal function, inhibiting macrophage glycolysis, reducing macrophage transformation to the M1 state, and suppressing the expression of the HIF-1α/PKM2 signaling pathway.

Conclusion: SHT may exert renoprotective effects by inhibiting macrophage glycolysis via the HIF-1α/PKM2 signaling pathway. This inhibition decreases macrophage M1 polarization and reduces immunoinflammatory injury in the renal tissue of DKD mice.

目的:研究参花片对糖尿病肾病(DKD)小鼠肾巨噬细胞极化及肾损伤的影响,探讨其可能涉及缺氧诱导因子-1α (HIF-1α)、丙酮酸激酶M2 (PKM2)信号通路及糖酵解代谢通路的机制。方法:将动物分为模型组、对照组、达格列净组、SHT低剂量组、SHT中剂量组、SHT高剂量组。我们评估了24小时尿蛋白(24 h-UTP)水平、尿白蛋白与肌酐比值,并在治疗期间定期监测空腹血糖。治疗后,我们检测了肾组织结构、肾功能(尿素氮、尿酸、肌酐、胱抑素C、β2微球蛋白)和肾巨噬细胞的糖酵解。此外,我们观察了肾组织中的巨噬细胞极化,并测量了炎症因子(肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6、白细胞介素-10、单核细胞趋化蛋白-1)来评估肾组织的免疫炎症状态。最后,我们研究了巨噬细胞中HIF-1α/ PKM2信号通路的表达,以探讨其在糖酵解过程中的作用。结果:SHT通过降低24 h-UTP,调节血糖水平,改善肾组织结构,保护肾功能,抑制巨噬细胞糖酵解,减少巨噬细胞向M1状态转化,抑制HIF-1α/PKM2信号通路的表达,对DKD有有益的治疗作用。结论:SHT可能通过HIF-1α/PKM2信号通路抑制巨噬细胞糖酵解,从而发挥肾保护作用。这种抑制降低了巨噬细胞M1极化,减轻了DKD小鼠肾组织的免疫炎症损伤。
{"title":"Exploring the mechanism of Shenhua tablet alleviating renal injury by regulating macrophage glycolysis hypoxia-inducible factor-1α/ pyruvate kinase M2 signaling pathway in diabetic kidney disease mice.","authors":"Chen Yuanchun, Jing Jiaxing, L I Qingmin, Zhou Xiaohong, Jin Xiaofei, Gao Weijuan, Chen Xiangmei, Y U Wentao","doi":"10.19852/j.cnki.jtcm.2025.03.009","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.009","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the impact of Shenhua tablet (, SHT) on renal macrophage polarization and renal injury in mice with diabetic kidney disease (DKD)and to explore the potential mechanism involving the hypoxia-inducible factor-1α (HIF-1α) and pyruvate kinase M2 (PKM2) signaling pathway, along with the glycolysis metabolism pathway.</p><p><strong>Methods: </strong>The animals were divided into the following groups: Model, Control, dapagliflozin, SHT low-dose, SHT medium-dose, and SHT high-dose. We assessed 24-hour urine protein (24 h-UTP) levels, urinary albumin-to-creatinine ratio, and regularly monitored fasting blood glucose during the treatment period. After treatment, we examined renal tissue structure, renal function (urea nitrogen, uric acid, creatinine, cystatin C, β2-microglobulin), and glycolysis in renal macrophages. Additionally, we observed macrophage polarization in renal tissue and measured inflammatory factors (tumor necrosis factor-α, interleukin-1β, interleukin-6, interleukin-10, monocyte chemoattractant protein-1) to assess the immunoinflammatory status of the renal tissue. Finally, we investigated the expression of the HIF-1α/ PKM2 signaling pathway in macrophages to explore its role in the glycolysis process.</p><p><strong>Results: </strong>SHT shows a beneficial effect in treating DKD by reducing 24 h-UTP, regulating blood glucose levels, improving renal tissue structure, protecting renal function, inhibiting macrophage glycolysis, reducing macrophage transformation to the M1 state, and suppressing the expression of the HIF-1α/PKM2 signaling pathway.</p><p><strong>Conclusion: </strong>SHT may exert renoprotective effects by inhibiting macrophage glycolysis <i>via</i> the HIF-1α/PKM2 signaling pathway. This inhibition decreases macrophage M1 polarization and reduces immunoinflammatory injury in the renal tissue of DKD mice.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"528-537"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134323/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prognostic model of immunoglobulin A nephropathy using artificial neural network: a retrospective study based on integrated Chinese and Western Medicine. 基于人工神经网络的免疫球蛋白A肾病预后模型:基于中西医结合的回顾性研究。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.002
Chen Hongyu, Zheng Xinyi, Wang Zeng, Ding Xiaoyu, X U Luhuan, Zhu Qin

Objective: To establish and evaluate a prognostic model of immunoglobulin A nephropathy (IgAN) based on integrated Chinese and Western Medicine.

Methods: Retrospective analysis from 1/1/2013 to 12/31/2015 was performed on 735 patients who were diagnosed with IgAN. In addition, 105 external data sets from 1/1/2016 to 12/31/2018 were used to verify the constructed model. The end point was entry into end-stage renal disease or a doubling of serum creatinine (Scr) level from baseline. Kaplan-Meier curve survival analysis and multivariable Cox regression analysis were used to find independent prognostic factors. MATLAB 2018b and artificial neural network (ANN) were used to construct prognostic risk factor prediction models each for Traditional Chinese Medicine (TCM), Western Medicine, and integrated TCM and Western Medicine. The ANN model incorporated WANG Yongjun's new five-type syndrome differentiation for IgAN. The prediction efficiencies of the three models were compared using the confusion matrix and the area under thecurve (AUC).

Results: Patients from 1/1/2013 to 12/31/2015 were followed for a mean of (46 ± 19) months. The 5-year median overall renal survival time was 58.6 months, and a total of 40 patients (5.4%) entered the endpoint. Ratio of males to females was 1.48:1. Median age of patients undergoing renal puncture was 35 years. Median 24-hour urinary protein was 0.55 g and 37 patients (5.0%) had pronounced proteinuria (24-hour urine protein ≥ 3.5 g). Median serum creatinine was 76 μmol/L and mean estimated glomerular filtration rate was (90 ± 33) mL/min per 1.73 m2. Oxford classification of renal pathology suggested a high rate of focal segmental glomeru-losclerosis (80.3%). Use of immunosuppressants was the most common (71.3%) treatment after renal puncture and improved clinical outcomes of IgAN. TCM differentiation of kidney deficiency was the most common syndrome (69.5%). Independent risk factors for the endpoint were male, anemia, high urinary protein, and an Oxford classification of segmental sclerosis (S). AUCs of the Western Medicine, TCM, and integrated Chinese and Western Medicine models were 0.89, 0.87, and 0.92, respectively. In external data (1/1/2016 to 12/31/2018), the performance of the three models was 0.88, 0.80, and 0.94, respectively.

Conclusions: ANN can be used to successfully construct a 5-year prediction model of IgAN after renal puncture. The efficiency of this model, which combines TCM and Western Medicine factors based on Wang's new five-type syndrome differentiation, exceeds that of Western Medicine factors or TCM factors alone in data from this single-center retrospective study.

目的:建立并评价基于中西医结合的免疫球蛋白a肾病(IgAN)预后模型。方法:对2013年1月1日至2015年12月31日诊断为IgAN的735例患者进行回顾性分析。此外,使用2016年1月1日至2018年12月31日的105个外部数据集对构建的模型进行验证。终点为进入终末期肾病或血清肌酐(Scr)水平较基线水平翻倍。Kaplan-Meier曲线生存分析和多变量Cox回归分析寻找独立预后因素。利用MATLAB 2018b和人工神经网络(ANN)分别构建中药、西药和中西医结合的预后危险因素预测模型。人工神经网络模型结合王勇军的IgAN新五型辨证。利用混淆矩阵和曲线下面积(AUC)对三种模型的预测效率进行了比较。结果:2013年1月1日至2015年12月31日,患者平均随访时间(46±19)个月。5年中位肾总生存时间为58.6个月,共有40例患者(5.4%)进入终点。男女比例为1.48:1。肾穿刺患者的中位年龄为35岁。24小时尿蛋白中位数为0.55 g, 37例(5.0%)出现明显的蛋白尿(24小时尿蛋白≥3.5 g)。血清肌酐中位数为76 μmol/L,肾小球滤过率平均为(90±33)mL/min / 1.73 m2。牛津肾病理分类提示局灶节段性肾小球硬化发生率高(80.3%)。使用免疫抑制剂是肾穿刺后最常见的治疗方法(71.3%),并改善了IgAN的临床结果。中医辨证以肾虚证最常见(69.5%)。终点的独立危险因素为男性、贫血、高尿蛋白和牛津节段性硬化症(S)。西医模型、中西医结合模型和中西医结合模型的auc分别为0.89、0.87和0.92。在外部数据(2016年1月1日至2018年12月31日)中,三种模型的性能分别为0.88、0.80和0.94。结论:ANN可成功构建肾穿刺后IgAN的5年预测模型。该模型以王氏新五型辨证为基础,结合中西医因素,在单中心回顾性研究数据中,其效率超过西医因素或中医因素单独。
{"title":"A prognostic model of immunoglobulin A nephropathy using artificial neural network: a retrospective study based on integrated Chinese and Western Medicine.","authors":"Chen Hongyu, Zheng Xinyi, Wang Zeng, Ding Xiaoyu, X U Luhuan, Zhu Qin","doi":"10.19852/j.cnki.jtcm.2025.03.002","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.002","url":null,"abstract":"<p><strong>Objective: </strong>To establish and evaluate a prognostic model of immunoglobulin A nephropathy (IgAN) based on integrated Chinese and Western Medicine.</p><p><strong>Methods: </strong>Retrospective analysis from 1/1/2013 to 12/31/2015 was performed on 735 patients who were diagnosed with IgAN. In addition, 105 external data sets from 1/1/2016 to 12/31/2018 were used to verify the constructed model. The end point was entry into end-stage renal disease or a doubling of serum creatinine (Scr) level from baseline. Kaplan-Meier curve survival analysis and multivariable Cox regression analysis were used to find independent prognostic factors. MATLAB 2018b and artificial neural network (ANN) were used to construct prognostic risk factor prediction models each for Traditional Chinese Medicine (TCM), Western Medicine, and integrated TCM and Western Medicine. The ANN model incorporated WANG Yongjun's new five-type syndrome differentiation for IgAN. The prediction efficiencies of the three models were compared using the confusion matrix and the area under thecurve (AUC).</p><p><strong>Results: </strong>Patients from 1/1/2013 to 12/31/2015 were followed for a mean of (46 ± 19) months. The 5-year median overall renal survival time was 58.6 months, and a total of 40 patients (5.4%) entered the endpoint. Ratio of males to females was 1.48:1. Median age of patients undergoing renal puncture was 35 years. Median 24-hour urinary protein was 0.55 g and 37 patients (5.0%) had pronounced proteinuria (24-hour urine protein ≥ 3.5 g). Median serum creatinine was 76 μmol/L and mean estimated glomerular filtration rate was (90 ± 33) mL/min per 1.73 m<sup>2</sup>. Oxford classification of renal pathology suggested a high rate of focal segmental glomeru-losclerosis (80.3%). Use of immunosuppressants was the most common (71.3%) treatment after renal puncture and improved clinical outcomes of IgAN. TCM differentiation of kidney deficiency was the most common syndrome (69.5%). Independent risk factors for the endpoint were male, anemia, high urinary protein, and an Oxford classification of segmental sclerosis (S). AUCs of the Western Medicine, TCM, and integrated Chinese and Western Medicine models were 0.89, 0.87, and 0.92, respectively. In external data (1/1/2016 to 12/31/2018), the performance of the three models was 0.88, 0.80, and 0.94, respectively.</p><p><strong>Conclusions: </strong>ANN can be used to successfully construct a 5-year prediction model of IgAN after renal puncture. The efficiency of this model, which combines TCM and Western Medicine factors based on Wang's new five-type syndrome differentiation, exceeds that of Western Medicine factors or TCM factors alone in data from this single-center retrospective study.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"676-684"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effect of Shugan Jieyu San for improving liver function and alleviating depression in patients with triple negative breast cancer. 疏肝解郁散改善三阴性乳腺癌患者肝功能、缓解抑郁的临床疗效。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.016
Zhang Yang, Lyu Wang, X U Xin, L I Jie, H U Shengli, Wang Ying

Objective: To evaluate the therapeutic effect of a self-formulated Traditional Chinese Medicine (TCM), Shugan Jieyu San, on improvement of liver function and depression alleviation in the patients with triple negative breast cancer (TNBC).

Methods: A total of 60 patients diagnosed with TNBC and depression were enrolled and randomly assigned to either the control group (receiving routine tumor treatment and duloxetine) or the treatment group (receiving the TCM in addition to routine treatment).

Results: Both treatment and control groups showed a reduction in depressive symptoms and improved daily living abilities after treatment. However, the treatment group demonstrated significantly better outcomes compared to the control group. Furthermore, the levels of dopamine and serotonin in the serum increased in both groups after 8 weeks of treatment, while the treatment group exhibited superior results.

Conclusions: This TCM showed promising results in reducing depressive symptoms and improving daily abilities in patients with TNBC and comorbid depression, which was verified by the increase in serum levels of dopamine and serotonin, suggesting the potential involvement of these neurotransmitters in the therapeutic effects of this TCM.

目的:评价中药疏肝解郁散对三阴性乳腺癌(TNBC)患者肝功能改善及抑郁缓解的疗效。方法:将60例确诊为TNBC合并抑郁症的患者随机分为对照组(常规肿瘤治疗加度洛西汀治疗)和治疗组(常规治疗加中药治疗)。结果:治疗组和对照组治疗后抑郁症状减轻,日常生活能力改善。然而,与对照组相比,治疗组表现出明显更好的结果。治疗8周后,两组患者血清中多巴胺和血清素水平均升高,治疗组效果更佳。结论:该中药对TNBC合并抑郁症患者的抑郁症状和日常生活能力有明显的改善作用,血清多巴胺和血清素水平的升高证实了这一点,提示这些神经递质可能参与了该中药的治疗效果。
{"title":"Clinical effect of Shugan Jieyu San for improving liver function and alleviating depression in patients with triple negative breast cancer.","authors":"Zhang Yang, Lyu Wang, X U Xin, L I Jie, H U Shengli, Wang Ying","doi":"10.19852/j.cnki.jtcm.2025.03.016","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.016","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the therapeutic effect of a self-formulated Traditional Chinese Medicine (TCM), Shugan Jieyu San, on improvement of liver function and depression alleviation in the patients with triple negative breast cancer (TNBC).</p><p><strong>Methods: </strong>A total of 60 patients diagnosed with TNBC and depression were enrolled and randomly assigned to either the control group (receiving routine tumor treatment and duloxetine) or the treatment group (receiving the TCM in addition to routine treatment).</p><p><strong>Results: </strong>Both treatment and control groups showed a reduction in depressive symptoms and improved daily living abilities after treatment. However, the treatment group demonstrated significantly better outcomes compared to the control group. Furthermore, the levels of dopamine and serotonin in the serum increased in both groups after 8 weeks of treatment, while the treatment group exhibited superior results.</p><p><strong>Conclusions: </strong>This TCM showed promising results in reducing depressive symptoms and improving daily abilities in patients with TNBC and comorbid depression, which was verified by the increase in serum levels of dopamine and serotonin, suggesting the potential involvement of these neurotransmitters in the therapeutic effects of this TCM.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"633-638"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jatropholone B from Jatropha curcas inhibits melanin synthesisextracellular signal-regulated kinase activation in Mel-Ab cell. 麻疯树麻风酚酮B抑制Mel-Ab细胞黑色素合成及胞外信号调节激酶激活。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.005
Harfina Finanda Anwar, Chang Seok Park, Marianti Manggau, Hye-Young Yun, Dong-Seok Kim

Objective: In the present study, we investigated the effects of jatropholone B from Jatropha curcas (J. curcas) on melanin synthesis in Mel-Ab cells.

Methods: Mel-Ab cells were cultured to measure melanin content and tyrosinase activities. Western blotting was performed to investigate jatropholone B-induced signal transduction and measure the expression of melanogenic proteins.

Results: Jatropholone B decreased melanin synthesis in a concentration-dependent manner but did not directly inhibit the activity of tyrosinase, a melanogenic enzyme. Instead, jatropholone B downregulated microphthalmia-associated transcription factor (MITF) and tyrosinase protein levels. Therefore, we investigated jatropholone B-induced signal transduction related to MITF and tyrosinase expression. However, jatropholone B had no significant effect on Akt and glycogen synthase kinase-3β phosphorylation as well as β-catenin change. In contrast, jatropholone B was observed to phosphorylate extracellular signal-regulated kinase (ERK) for the first time. To clarify the involvement of ERK activation in jatropholone B-induced hypopigmentation, we pretreated cells with PD98059, a specific ERK pathway inhibitor, and measured MITF and tyrosinase levels as well as melanin content. PD98059 pretreatment abrogated jatropholone B-induced downregulation of MITF and tyrosinase expression as well as reduction in melanin production.

Conclusions: Based on these results, we suggest that ERK activation by jatropholone B inhibits melanogenesis via the downregulation of MITF and tyrosinase expression. Therefore, jatropholone B from J. curcas can be a candidate for developing a new skin-whitening agent.

目的:研究麻疯树提取物麻风酚酮B对Mel-Ab细胞黑色素合成的影响。方法:培养Mel-Ab细胞,测定黑色素含量和酪氨酸酶活性。Western blotting检测麻疯酚b诱导的信号转导及黑素蛋白的表达。结果:麻风酮B抑制黑色素合成呈浓度依赖性,但不直接抑制酪氨酸酶活性。相反,麻风酮B下调了小眼相关转录因子(MITF)和酪氨酸酶蛋白水平。因此,我们研究了麻疯酚b诱导的与MITF和酪氨酸酶表达相关的信号转导。而麻风酮B对Akt和糖原合成酶激酶3β磷酸化及β-catenin变化无显著影响。相比之下,麻风酮B首次被观察到磷酸化细胞外信号调节激酶(ERK)。为了阐明ERK激活在麻风酮b诱导的色素减退中的作用,我们用PD98059(一种特异性ERK通路抑制剂)预处理细胞,并测量MITF和酪氨酸酶水平以及黑色素含量。PD98059预处理消除了麻疯酚b诱导的MITF和酪氨酸酶表达下调以及黑色素生成减少。结论:基于这些结果,我们认为麻风酚酮B激活ERK通过下调MITF和酪氨酸酶的表达来抑制黑素生成。因此,麻疯酚B可作为开发新型皮肤增白剂的候选物质。
{"title":"Jatropholone B from Jatropha curcas inhibits melanin synthesisextracellular signal-regulated kinase activation in Mel-Ab cell.","authors":"Harfina Finanda Anwar, Chang Seok Park, Marianti Manggau, Hye-Young Yun, Dong-Seok Kim","doi":"10.19852/j.cnki.jtcm.2025.03.005","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.005","url":null,"abstract":"<p><strong>Objective: </strong>In the present study, we investigated the effects of jatropholone B from <i>Jatropha curcas</i> (<i>J. curcas</i>) on melanin synthesis in Mel-Ab cells.</p><p><strong>Methods: </strong>Mel-Ab cells were cultured to measure melanin content and tyrosinase activities. Western blotting was performed to investigate jatropholone B-induced signal transduction and measure the expression of melanogenic proteins.</p><p><strong>Results: </strong>Jatropholone B decreased melanin synthesis in a concentration-dependent manner but did not directly inhibit the activity of tyrosinase, a melanogenic enzyme. Instead, jatropholone B downregulated microphthalmia-associated transcription factor (MITF) and tyrosinase protein levels. Therefore, we investigated jatropholone B-induced signal transduction related to MITF and tyrosinase expression. However, jatropholone B had no significant effect on Akt and glycogen synthase kinase-3β phosphorylation as well as β-catenin change. In contrast, jatropholone B was observed to phosphorylate extracellular signal-regulated kinase (ERK) for the first time. To clarify the involvement of ERK activation in jatropholone B-induced hypopigmentation, we pretreated cells with PD98059, a specific ERK pathway inhibitor, and measured MITF and tyrosinase levels as well as melanin content. PD98059 pretreatment abrogated jatropholone B-induced downregulation of MITF and tyrosinase expression as well as reduction in melanin production.</p><p><strong>Conclusions: </strong>Based on these results, we suggest that ERK activation by jatropholone B inhibits melanogenesis <i>via</i> the downregulation of MITF and tyrosinase expression. Therefore, jatropholone B from J. curcas can be a candidate for developing a new skin-whitening agent.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"485-492"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134309/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rotating-pulling-poking manipulation in gait analysis for lateral ankle sprain treatment. 旋转-拉-戳手法治疗踝关节外侧扭伤的步态分析。
Pub Date : 2025-06-01 DOI: 10.19852/j.cnki.jtcm.2025.03.019
Feng Mingshan, Wen Haibao, Zhao Wenlong, Han Changxiao, Gao Chunyu, L I Luguang, Zou Jinqiao, D U Wuyin, Zhu Liguo, Gao Jinghua

Objective: To compare the changes in gait parameters before and after the treatment of lateral ankle sprain using the rotating-pulling-poking manipulation, and explore the potential bio-mechanical mechanism of this manipulation.

Methods: Forty patients with lateral ankle sprains were randomly divided into two groups in a 1:1 ratio using a random number table. The experimental group were treated by rotating-pulling-poking manipulation and elastic bandage external fixation, while the control group were treated by ice compress and elastic bandage external fixation. The treatment courses of the two groups were both 2 weeks. We used a three-dimensional motion capture system for kinematic measurements and a Bertec gait analysis force measurement system for mechanical measurements, and compared the changes in gait parameters between the two groups of patients before and after treatment.

Results: Intragroup comparison showed that the support time, swing time, peak of back extension, peak of plantar flexion, peak of toe pedal force, and peak of heel landing force of the affected feet in the experimental group were significantly improved compared to those before treatment (P < 0.05). The swing time of the affected feet in the control group was significantly improved compared to that before treatment (P < 0.05). The inter group comparison showed that the gait speed, stride length, peak of back extension, peak of plantar flexion, peak of toe pedal force, and peak of heel landing force of the affected feet in the experimental group were significantly better than those in the control group (P < 0.05).

Conclusions: The rotating-pulling-poking manipulation can effectively improve the patient's gait and range of motion of the affected ankle joint, and enhance the negative gravity in the vertical direction of the affected foot, and the braking and driving forces in the front and back directions. This may be the potential biomechanical mechanism of the rotating-pulling-poking manipulation for treating lateral ankle sprain.

目的:比较旋转-拉扯-戳手法治疗踝关节外侧扭伤前后步态参数的变化,并探讨该手法潜在的生物力学机制。方法:采用随机数字表法,将40例踝关节外侧扭伤患者按1:1的比例随机分为两组。实验组采用转拉戳手法加弹性绷带外固定,对照组采用冰敷加弹性绷带外固定。两组疗程均为2周。我们使用三维运动捕捉系统进行运动学测量,使用Bertec步态分析力测量系统进行力学测量,比较两组患者治疗前后步态参数的变化。结果:组内比较,实验组患足支撑时间、摆动时间、后伸峰值、足底屈曲峰值、足趾蹬力峰值、足跟着地力峰值均较治疗前显著改善(P < 0.05)。对照组患足摆动时间较治疗前明显改善(P < 0.05)。组间比较,实验组患足的步速、步长、背伸峰值、足底屈曲峰值、足尖蹬力峰值、足跟落地力峰值均显著优于对照组(P < 0.05)。结论:旋转-拉-戳手法可有效改善患者的步态和患踝关节的活动范围,增强患足垂直方向的负重力和前后方向的制动力。这可能是旋转-拉扯-戳手法治疗外侧踝关节扭伤的潜在生物力学机制。
{"title":"Rotating-pulling-poking manipulation in gait analysis for lateral ankle sprain treatment.","authors":"Feng Mingshan, Wen Haibao, Zhao Wenlong, Han Changxiao, Gao Chunyu, L I Luguang, Zou Jinqiao, D U Wuyin, Zhu Liguo, Gao Jinghua","doi":"10.19852/j.cnki.jtcm.2025.03.019","DOIUrl":"10.19852/j.cnki.jtcm.2025.03.019","url":null,"abstract":"<p><strong>Objective: </strong>To compare the changes in gait parameters before and after the treatment of lateral ankle sprain using the rotating-pulling-poking manipulation, and explore the potential bio-mechanical mechanism of this manipulation.</p><p><strong>Methods: </strong>Forty patients with lateral ankle sprains were randomly divided into two groups in a 1:1 ratio using a random number table. The experimental group were treated by rotating-pulling-poking manipulation and elastic bandage external fixation, while the control group were treated by ice compress and elastic bandage external fixation. The treatment courses of the two groups were both 2 weeks. We used a three-dimensional motion capture system for kinematic measurements and a Bertec gait analysis force measurement system for mechanical measurements, and compared the changes in gait parameters between the two groups of patients before and after treatment.</p><p><strong>Results: </strong>Intragroup comparison showed that the support time, swing time, peak of back extension, peak of plantar flexion, peak of toe pedal force, and peak of heel landing force of the affected feet in the experimental group were significantly improved compared to those before treatment (<i>P <</i> 0.05). The swing time of the affected feet in the control group was significantly improved compared to that before treatment (<i>P <</i> 0.05). The inter group comparison showed that the gait speed, stride length, peak of back extension, peak of plantar flexion, peak of toe pedal force, and peak of heel landing force of the affected feet in the experimental group were significantly better than those in the control group (<i>P <</i> 0.05).</p><p><strong>Conclusions: </strong>The rotating-pulling-poking manipulation can effectively improve the patient's gait and range of motion of the affected ankle joint, and enhance the negative gravity in the vertical direction of the affected foot, and the braking and driving forces in the front and back directions. This may be the potential biomechanical mechanism of the rotating-pulling-poking manipulation for treating lateral ankle sprain.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":"45 3","pages":"667-675"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144311053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1